These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 11513170

  • 41. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
    Katsinelos P, Tziomalos K, Chatzimavroudis G, Vasiliadis T, Katsinelos T, Pilpilidis I, Triantafillidis I, Paroutoglou G, Papaziogas B.
    Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
    [Abstract] [Full Text] [Related]

  • 42. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC, Lee CL, Chan CC, Tu TC, Liao CC, Wu CH, Chen TK.
    Arch Intern Med; 2003 Sep 22; 163(17):2020-4. PubMed ID: 14504114
    [Abstract] [Full Text] [Related]

  • 43. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE, Dickson A, El-Nujumi A, El-Omar E, Kelman A.
    Am J Gastroenterol; 2000 Jan 22; 95(1):101-5. PubMed ID: 10638566
    [Abstract] [Full Text] [Related]

  • 44. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
    Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T.
    J Gastroenterol Hepatol; 2005 Nov 22; 20(11):1652-60. PubMed ID: 16246181
    [Abstract] [Full Text] [Related]

  • 45. Helicobacter pylori eradication in functional dyspepsia: HEROES trial.
    Mazzoleni LE, Sander GB, Francesconi CF, Mazzoleni F, Uchoa DM, De Bona LR, Milbradt TC, Von Reisswitz PS, Berwanger O, Bressel M, Edelweiss MI, Marini SS, Molina CG, Folador L, Lunkes RP, Heck R, Birkhan OA, Spindler BM, Katz N, Colombo Bda S, Guerrieri PP, Renck LB, Grando E, Hocevar de Moura B, Dahmer FD, Rauber J, Prolla JC.
    Arch Intern Med; 2011 Nov 28; 171(21):1929-36. PubMed ID: 22123802
    [Abstract] [Full Text] [Related]

  • 46. Lansoprazole and Helicobacter pylori infection.
    Pallone F, Luzza F, Delle Fave G, Annibale B, Marcheggiano A, Biancone L, Torsoli A, Capurso L.
    Clin Ther; 1993 Nov 28; 15 Suppl B():49-57. PubMed ID: 8205595
    [Abstract] [Full Text] [Related]

  • 47. Eradication of Helicobacter pylori followed by reinfection.
    Tonokatsu Y, Fukuda Y, Tsujiai T, Tamura K, Shimoyama T.
    J Gastroenterol; 1996 Nov 28; 31 Suppl 9():75-6. PubMed ID: 8959526
    [Abstract] [Full Text] [Related]

  • 48. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF, Carvalhaes A, Natan-Eisig J, Paraíso-Ferraz JG, Trevisan M, Zaterkaad S.
    Gastroenterol Hepatol; 2005 Oct 28; 28(8):441-4. PubMed ID: 16185577
    [Abstract] [Full Text] [Related]

  • 49. The effect of antibiotic therapy on bleeding from duodenal ulcer.
    Sonnenberg A, Olson CA, Zhang J.
    Am J Gastroenterol; 1999 Apr 28; 94(4):950-4. PubMed ID: 10201462
    [Abstract] [Full Text] [Related]

  • 50. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
    Talley NJ, Janssens J, Lauritsen K, Rácz I, Bolling-Sternevald E.
    BMJ; 1999 Mar 27; 318(7187):833-7. PubMed ID: 10092259
    [Abstract] [Full Text] [Related]

  • 51. [Lansoprazole: a review of its role in Helicobacter pylori eradication therapy].
    Gisbert JP.
    Rev Esp Enferm Dig; 1999 Feb 27; 91(2):133-43. PubMed ID: 10231305
    [Abstract] [Full Text] [Related]

  • 52. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
    Mazzoleni LE, Sander GB, Ott EA, Barros SG, Francesconi CF, Polanczyk CA, Wortmann AC, Theil AL, Fritscher LG, Rivero LF, Cartell A, Edelweiss MI, Uchôa DM, Prolla JC.
    Dig Dis Sci; 2006 Jan 27; 51(1):89-98. PubMed ID: 16416218
    [Abstract] [Full Text] [Related]

  • 53. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
    Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M.
    Lancet; 2001 Jun 02; 357(9270):1738-42. PubMed ID: 11403809
    [Abstract] [Full Text] [Related]

  • 54. Nonulcer dyspepsia and Helicobacter pylori, with comment on posteradication symptoms.
    Goodwin S, Kassar-Juma W, Jazrawi R, Benson M, Northfield T.
    Dig Dis Sci; 1998 Sep 02; 43(9 Suppl):67S-71S. PubMed ID: 9753229
    [Abstract] [Full Text] [Related]

  • 55. Endoscopic topical therapy for the treatment of Helicobacter pylori infection.
    Kihira K, Satoh K, Saifuku K, Taniguchi Y, Takimoto T, Yoshida Y, Ishino Y, Yamamoto H, Kimura K.
    J Gastroenterol; 1996 Nov 02; 31 Suppl 9():66-8. PubMed ID: 8959524
    [Abstract] [Full Text] [Related]

  • 56. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment.
    Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY.
    Am J Gastroenterol; 1996 Mar 02; 91(3):441-7. PubMed ID: 8633488
    [Abstract] [Full Text] [Related]

  • 57. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
    Sonnenberg A, Pauly MP, Levenson SD, Schwartz JS.
    Am J Manag Care; 1999 Jan 02; 5(1):53-9. PubMed ID: 10345967
    [Abstract] [Full Text] [Related]

  • 58. [Treatment of Helicobacter pylori infection].
    Lamouliatte H, Cayla R, Mégraud F.
    Rev Prat; 2000 Sep 01; 50(13):1442-5. PubMed ID: 11019637
    [Abstract] [Full Text] [Related]

  • 59. Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat?
    Hammett DC, Evans MF.
    Can Fam Physician; 1999 Oct 01; 45():2323-6. PubMed ID: 10540692
    [No Abstract] [Full Text] [Related]

  • 60. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
    Bytzer P, Teglbjaerg PS, Danish Ulcer Study Group.
    Am J Gastroenterol; 2001 May 01; 96(5):1409-16. PubMed ID: 11374675
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.